Minneapolis Clinical Trials
2307 Treatment Study
Participate in a clinical study to help find a potential new treatment for atherosclerotic cardiovascular disease (ASCVD).
7 nights
4 visits
Nucleus Network is looking at how a new study treatment for lowering LDL cholesterol is processed in people with moderate hepatic impairment.
Study Duration:
- Screen: 1 screen appointment
- Inpatient: 7 nights/ 8 days
- Outpatient: 2 outpatient visits and 1 end of study phone call
Get reimbursed up to $4,850 for your time.
Call 612-315-6490 to discuss your eligibility today!
Eligibility
Age: 18-75
BMI: 17.5-42 kg/m2
Compensation: Up to $4850
Population: Moderate liver impairment